These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 35952593)
21. Copper ion incorporation in α-synuclein amyloids. Walke G; Kumar R; Wittung-Stafshede P Protein Sci; 2024 Apr; 33(4):e4956. PubMed ID: 38511511 [TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders. Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160 [TBL] [Abstract][Full Text] [Related]
23. Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease. Bisaglia M; Tessari I; Mammi S; Bubacco L Neuromolecular Med; 2009; 11(4):239-51. PubMed ID: 19669606 [TBL] [Abstract][Full Text] [Related]
24. Modulation Effects of Fe Li Y; Yu Y; Ma G Molecules; 2022 Dec; 27(23):. PubMed ID: 36500474 [TBL] [Abstract][Full Text] [Related]
26. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease. Bharathi P; Nagabhushan P; Rao KS Comput Biol Med; 2008 Oct; 38(10):1084-93. PubMed ID: 18823621 [TBL] [Abstract][Full Text] [Related]
27. DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with α-synuclein through hydrophobic interaction. Zhu M; H Patel S; Han S Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1759-1769. PubMed ID: 28330770 [TBL] [Abstract][Full Text] [Related]
28. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species. Singh P; Bhat R ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654 [TBL] [Abstract][Full Text] [Related]
29. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease. Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094 [TBL] [Abstract][Full Text] [Related]
30. Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system. Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH Free Radic Biol Med; 2002 Mar; 32(6):544-50. PubMed ID: 11958955 [TBL] [Abstract][Full Text] [Related]
31. Role of Sporadic Parkinson Disease Associated Mutations A18T and A29S in Enhanced α-Synuclein Fibrillation and Cytotoxicity. Kumar S; Jangir DK; Kumar R; Kumari M; Bhavesh NS; Maiti TK ACS Chem Neurosci; 2018 Feb; 9(2):230-240. PubMed ID: 28841377 [TBL] [Abstract][Full Text] [Related]
32. Interaction between Copper Chaperone Atox1 and Parkinson's Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells. Horvath I; Blockhuys S; Šulskis D; Holgersson S; Kumar R; Burmann BM; Wittung-Stafshede P ACS Chem Neurosci; 2019 Nov; 10(11):4659-4668. PubMed ID: 31600047 [TBL] [Abstract][Full Text] [Related]
33. Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism. McLeary FA; Rcom-H'cheo-Gauthier AN; Kinder J; Goulding M; Khoo TK; Mellick GD; Chung RS; Pountney DL Neurotox Res; 2018 Feb; 33(2):229-238. PubMed ID: 29064068 [TBL] [Abstract][Full Text] [Related]
34. Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease. Yan M; Meng L; Dai L; Zhang X; Chen G; Zheng Y; Zha Y; Zeng Y; Zhang Z Biochem Biophys Res Commun; 2020 Sep; 529(4):1053-1060. PubMed ID: 32819564 [TBL] [Abstract][Full Text] [Related]
35. Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state. Högen T; Levin J; Schmidt F; Caruana M; Vassallo N; Kretzschmar H; Bötzel K; Kamp F; Giese A Biophys J; 2012 Apr; 102(7):1646-55. PubMed ID: 22500765 [TBL] [Abstract][Full Text] [Related]
36. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers. Drew SC Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154 [TBL] [Abstract][Full Text] [Related]
37. alpha-Synuclein membrane interactions and lipid specificity. Jo E; McLaurin J; Yip CM; St George-Hyslop P; Fraser PE J Biol Chem; 2000 Nov; 275(44):34328-34. PubMed ID: 10915790 [TBL] [Abstract][Full Text] [Related]
38. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins. Jain MK; Singh P; Roy S; Bhat R Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342 [TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336 [TBL] [Abstract][Full Text] [Related]
40. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers. Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]